Ammann R W
Abteilung für Gastroenterologie, Universitätsspital Zürich, 8092 Zürich, Schweiz.
Chirurg. 2000 Jan;71(1):9-15. doi: 10.1007/s001040050002.
An overview is presented of the various therapy options in cystic and alveolar echinococcosis based on the recent literature and upon personal experience with chemotherapy over the last 20 years. In regions with an optimal surgical infrastructure and relatively small patient cohorts, long-term chemotherapy is practically limited to patients with inoperable echinococcosis, i. e. < 10 % cystic and around 70 % alveolar echinococcosis.
基于近期文献以及过去20年化疗的个人经验，本文对囊性和泡型棘球蚴病的各种治疗选择进行了概述。在具备最佳手术条件且患者群体相对较小的地区，长期化疗实际上仅限于患有无法手术的棘球蚴病的患者，即<10%的囊性棘球蚴病患者和约70%的泡型棘球蚴病患者。
